James A. Nash

Former Vice President-Technology Development at Shire ViroPharma, Inc.

James A. Nash

James A. Nash

Former Vice President-Technology Development at Shire ViroPharma, Inc.

Overview
Career Highlights

Napo Pharmaceuticals, Inc.

RelSci Relationships

1163

Birthday

1951

Age

69

Relationships
RelSci Relationships are individuals James A. Nash likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Director at Tanvex Biopharma, Inc.

Relationship likelihood: Strong

Chairman of the Board & Chief Executive Officer at Bausch Health Cos., Inc.

Relationship likelihood: Average

Chief Regulatory & Quality Officer at Vor Biopharma, Inc.

Relationship likelihood: Average

Executive Vice President, Chief Commercial Officer-Generics at Amneal Pharmaceuticals, Inc.

Relationship likelihood: Average

Former Senior Vice President-Quality Assurance at Actavis, Inc.

Relationship likelihood: Average

The University of Utah

Relationship likelihood: Average

Former Executive Director-Quality Operations at Watson Laboratories, Inc.

Relationship likelihood: Average

Former Senior Corporate Counsel, Corporate Counsel & Assistant Secretary at Actavis, Inc.

Relationship likelihood: Average

Chief Executive Officer at Hikma Pharmaceuticals Plc

Relationship likelihood: Average

Chief Operating Officer & Chief Scientific Officer at Catalyst Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to James A. Nash
Potential Connections via
Relationship Science
You
James A. Nash
Former Vice President-Technology Development at Shire ViroPharma, Inc.
Career History
Vice President-Manufacturing
1977 - 2000

G.D. Searle & Company or just Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health. Searle was founded in Omaha, Nebraska, in 1888. The founder was Gideon Daniel Searle. In 1908, the company was incorporated in Chicago. In 1941, the company established headquarters in Skokie, Illinois. It was acquired by the Monsanto Company in 1985. Pharmacia Corporation was created in April 2000 through the merger of Pharmacia & Upjohn (itself the result of the merger of Pharmacia and Upjohn) with the Monsanto Company and its G.D. Searle unit. Pfizer acquired Pharmacia in 2003 and retired the Searle name.

Senior Vice President-Technology Development & Operations
2002 - 2004

Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

Senior Vice President-Technology Development & Operations
2002 - 2004

Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James A. Nash. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James A. Nash's profile does not indicate a business or promotional relationship of any kind between RelSci and James A. Nash.